SAR444881

· Sanofi

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAR444881, covering 2025-08-07 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors [Phase 2]